Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh

Thomas Jefferson University Hospital, Philadelphia

University of Virginia Cancer Center, Charlottesville

Vanderbilt University/Ingram Cancer Center, Nashville

Wayne State University/Karmanos Cancer Institute, Detroit

University of Wisconsin Carbone Cancer Center - University Hospital, Madison

Mayo Clinic in Rochester, Rochester

M D Anderson Cancer Center, Houston

Mayo Clinic Hospital in Arizona, Phoenix

Mayo Clinic in Arizona, Scottsdale

UC San Diego Moores Cancer Center, La Jolla

UC San Diego Medical Center - Hillcrest, San Diego

Mayo Clinic in Florida, Jacksonville

Massachusetts General Hospital Cancer Center, Boston

Brigham and Women's Hospital, Boston

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston